The Canary Staked INJ ETF, ticker INJC, began trading on Nasdaq on November 5 after the exchange’s November 4 listing notice. The fund seeks exposure to INJ, the native token of the Injective network, while reflecting net staking rewards in its net asset value. The product gives investors access through a conventional brokerage account, but owning fund shares is not the same as directly holding, controlling or governing INJ in a self-custodied wallet. The ETF uses a registered fund structure but is not registered under the U.S. Investment Company Act of 1940, so it does not carry the same regulation and protections as funds registered under that law. Investors must also account for fund expenses, staking arrangements, validator performance, liquidity and the volatility of the underlying token. Its longer-term demand and liquidity will depend on assets, flows, trading volumes, spreads, fees and the way staking income is recorded.